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Edited by Jesus AvilaAbstract In this study, we investigated whether the increase of
inhibitory c-amino butyric acid (GABA) signal suppresses the
excitatory glutamate signal induced by cerebral ischemia and
the underlying mechanisms. In global cerebral ischemia, focal
cerebral ischemia and oxygen-glucose deprivation, application
of muscimol and baclofen, agonists of GABA(A) receptor and
GABA(B) receptor, exerted neuroprotection. The agonists inhib-
ited the increased assembly of the GluR6-PSD-95-MLK3 mod-
ule induced by cerebral ischemia and the activation of the
MLK3-MKK4/7-JNK3 cascade. Our results suggest that stimu-
lation of the inhibitory GABA receptors can attenuate the excit-
atory JNK3 apoptotic signaling pathway via inhibiting the
increased assembly of the GluR6-PSD-95-MLK3 signaling mod-
ule in cerebral ischemia.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Gamma-aminobutyric acid (GABA) is the major inhibitory
neurotransmitter in the central nervous system. Thus GABA
release in cerebral ischemia is also likely to be important, be-
cause it can alter concentration of extracellular glutamate [1].
GABA activates three types of speciﬁc receptors: GABA(A),
GABA(B) and GABA(C) receptors. At present, little is known
about GABA(C) receptor-mediated events. GABA(B) recep-
tors are metabotropic and seven transmembrane receptors that
are G-proteins-coupled and mediate the GABA signaling via
several second messenger pathways and Ca2+ and K+ ion
channels, whilst stimulation of ionotropic GABA(A) receptors
results in opening the chloride channel [2]. Previous studies
suggest that the pharmacologically increased level of GABAAbbreviations: NMDA, N-methyl-D-aspartic acid; GABA, c-amino
butyric acid
*Corresponding author. Fax: +86 516 8574 8486.
E-mail address: gyzhang@xzmc.edu.cn (G.-Y. Zhang).
1These authors contribute equally to this work.
0014-5793/$34.00  2008 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2008.02.044activity is correlated with lessened degree of brain ischemic in-
jury [3–5]. Other investigators, however, have not been able to
demonstrate the beneﬁt about those activating GABA recep-
tors in ischemia, particularly those agents relatively speciﬁc
for the GABA-B receptor [6]. Therefore, the possible neuro-
protective mechanism of GABA receptors activation in cere-
bral ischemia remains to be elucidated.
Our recent studies show that GluR6 (subunit of KA recep-
tor) are activated upon cerebral ischemia, and the assembling
of GluR6-PSD-95-MLK3 module, MLK3 autophosphoryla-
tion and the downstream phosphorylation of MKK4/7,
JNK3, c-Jun and Bcl-2 increased markedly in ischemia/reper-
fusion. Also, the expression of Fas-Ligand, the release of
Bax from Bcl-2/Bax dimmers and the release of cytochrome
c from mitochondria markedly increased. Consequently, the
activation of Caspase 3 lead to delayed neuronal death in the
hippocampal CA1 subﬁeld [7–9]. Thus, the present study was
aimed to identify whether stimulation of the inhibitory GABA
receptors have neuroprotective eﬀects thorough inhibiting the
excitatory JNK3 apoptotic pathway via disassembly of
GluR6-PSD95-MLK3 signaling module in cerebral ischemic-
reperfusion, so as to ﬁnd better therapeutic approach to cere-
bral ischemia.2. Materials and methods
2.1. Animal model of ischemia
Adult male SD rats (Shanghai Experimental Animal Center, Chinese
Academy of Science) weighing 250–300 g were used. Four-vessel occlu-
sion (4-VO) cerebral ischemia was induced as described before [1].
Brieﬂy, under anaesthesia with chloral hydrate (350 mg/kg, i.p.), verte-
bral arteries were electrocauterized and common carotid arteries were
exposed. Rats were allowed to recover for 24 h and fasted overnight.
Ischemia was induced by occluding the common arteries with aneu-
rysm clips. Rats which lost their righting reﬂex within 30 s and whose
pupils were dilated and unresponsive to light during ischemia were se-
lected for the experiments. An EEG was monitored to ensure isoelec-
tricity within 30 s after carotid artery occlusion. Carotid artery blood
ﬂow was restored by releasing the clips. Rectal temperature was con-
trolled at 36.5–37.5 C before and after ischemia–reperfusion and after
treatment with drugs via a temperature-regulated heating pad. Sham
control animals received the same surgical procedures except that car-
otid arteries were not occluded.
Focal cerebral ischemia was induced by the intraluminal suture
MCAo method as described in Longa et al. [2]. Brieﬂy, the left com-
mon carotid artery (CCA), internal carotid artery (ICA), and external
carotid artery (ECA) were exposed through a midline incision of theblished by Elsevier B.V. All rights reserved.
Fig. 1. Eﬀects of muscimol and/or baclofen on neuronal injury in cerebral ischemia and on infarction size in MCAOmodel. (A) Cresyl violet staining
was performed on the sections from the hippocampi in sham (a, b), and rats subjected to 5 days of reperfusion after 15 min of ischemia (c, d),
administration of the vehicle (e, f), muscimol (1 mg/kg) (g, h), baclofen (20 mg/kg) (i, j), muscimol and baclofen (k, l) before ischemia. Treatment with
muscimol and/or baclofen signiﬁcantly increased the number of the survival neurons at 5 days of reperfusion in the CA1 region. (B) Quantitative
analysis of the protective eﬀects of muscimol and/or baclofen against ischemic injury. Data were obtained from ﬁve independent animals and a
typical experiment is presented. Cell density was expressed as the number of cells per 1-mm length of the CA1 pyramidal cells counted under a light
microscope. Scale bars: k = 400 lm; l = 10 lm. aP < 0.05 versus sham control, bP < 0.05 versus saline treatment group. cP < 0.05 versus muscimol or
baclofen treatment group. (C) Muscimol and baclofen reduced the infarction volume in 24 h of MCAO rats. The MCA was occluded by a thread
inserted through the carotid artery. The animal was sacriﬁced after 24 h, and brain tissue was cut and stained with TTC. The non-stained (white) area
indicates infarct size. (D) The amount of injury was expressed as a ratio of the total infarct volume to the total volume of the damaged hemisphere.
aP < 0.05 versus saline treatment group (n = 5 per group).
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was inserted via the ECA. The occluder was inserted through a stump
of the ECA and the CCA was kept intact. The occluder was advanced
into the ICA about 20 mm beyond the carotid bifurcation. Mild resis-
tance indicated that the occluder was properly lodged in the anterior
cerebral artery and thus blocked blood ﬂow to the middle cerebral ar-
tery. At 1 h after MCAO, reperfusion began with the suture with-
drawn. In sham-operated animals, the suture was inserted 5 mm
from the incision.
2.2. Oxygen–glucose deprivation, evaluation of apoptosis and cell
viability
For oxygen–glucose deprivation (OGD), glucose-free Earls balanced
salt solution (EBSS) medium supplemented with gentamycin (5 mg/l)
was purged with N2/CO2 (95%/5%) for 20 min, resulting in an oxygen
content of 1%. Neurons were then washed three times with this mediumand incubated for 1 h in an oxygen-free N2/CO2 (95%/5%) atmosphere.
Control cultures were incubated in EBSS with 10 mM glucose. There-
after, the medium was replaced by standard culture medium. For
24 h after onset of OGD, cultured neurons were stained with the ﬂuo-
rescent DNA-binding dye 4 0,6-diamidino-2-phenylindole dihydrochlo-
ride (DAPI) and quantiﬁcation of cell death was performed. Stained
nuclei were visualized under epiﬂuorescence illumination (340 nm exci-
tation and 510 nm barrier ﬁlter) using a 20· objective. Neurons with
condensed and fragmented nuclei were considered apoptotic.
2.3. Electrophysiological recording
Electrophysiological recording was performed in the conventional
whole-cell patch-clamp recording conﬁguration under voltage-clamp
conditions. Patch pipettes were pulled from glass capillaries with an
outer diameter of 1.5 mm on a two-stage puller (PP-830, Narishige).
The resistance between the recording electrode ﬁlled with pipette solu-
Fig. 2. Muscimol and baclofen attenuates oxygen-glucose deprivation-induced neuronal cell death in hippocampal neurons. (A, B) Staining with
DAPI (dark blue) allowed the identiﬁcation of nuclear. Hippocampal neurons were pretreated with muscimol and baclofen for the indicated
concentration 30 min before OGD. Survival cells were indicated as the percentage of every 300 cells. Cell viability in OGD-induced cultures
pretreated with muscimol and baclofen was signiﬁcantly enhanced compared with controls. aP < 0.05 versus I/R 24 h group, bP < 0.05 versus
muscimol + baclofen 1–2 lmol/L treatment group, cP < 0.05 versus muscimol and baclofen 5 lmol/L or 15 lmol/L treatment group. (C, D)
Muscimol and baclofen applied at concentration of 15 lmol/L signiﬁcantly decreased the OGD-induced apoptosis-like cells. In group b, muscimol
and baclofe had no eﬀect on the cell viability without OGD. aP < 0.05 versus sham or sham + muscimol + baclofen group, bP < 0.05 versus I/R 24 h
group.
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measured using a patch-clamp ampliﬁer AxonPatch 700B (Axon
Instruments, Foster City, CA, USA), ﬁltered at 1 kHz, sampled and
analyzed using a DigiData 1322A interface and a computer with the
pClamp 9.0 system (Axon Instruments). The series resistance was com-
pensated automated. The membrane potential was held at 60 mV
throughout the experiment. All experiments were carried out at room
temperature (22 – 25 C).
2.4. Immunohistochemistry
Rats were anesthetized with chloral hydrate and underwent trans-
cardial perfusion with 0.9% saline followed by 4% paraformaldehyde
in 0.1 M phosphate buﬀer (PBS). Brains were removed, post-ﬁxed
overnight in paraformaldehyde, processed and embedded in paraﬃn.
Coronal brain sections (6-lm thick) were cut on a microtome (LeicaFig. 3. Cross-inhibition of GABAA and GABAB receptor with KA recepto
GABAB receptor inhibited KA receptor-mediated whole-cell currents in cultu
inhibited by non-NMDA GluR inhibitor CNQX. (B) Cross-inhibition of GAB
Co-application of GABAA receptor activator Mus or GABAB receptor act
activation of GABAA receptors and GABAB receptors on the KA receptor-m
Mus and Bac or single application of Mus without KA induced whole-cell cur
receptor-mediated whole-cell currents. All data here are expressed as means ±
compared with the group of KA +Mus + Bac, cP < 0.05 compared with th
15 lM; Bac: baclofen 15 lM.RM2155, Nussloch, Germany). Sections were de-paraﬃnized in xylene
and rehydrated in a gradient of ethanol and distilled water. High-tem-
perature antigen retrieval was performed in 1 mM citrate buﬀer. To
block endogenous peroxidase activity, sections were incubated for
2 h in a solution containing 0.01% sodium azide and 0.1% H2O2 in
PBS. To reduce non-speciﬁc staining, sections were incubated for 2 h
in a blocking solution containing 1% BSA, 2% normal goat serum,
0.3% Triton X-100 and 5% non-fat dry milk in PBS. The sections were
then incubated in the primary antibodies overnight at 4 C. Alternate
sections from each brain were incubated without primary antibody as
negative controls. After washes three times in PBS, the sections were
incubated for 2 h in biotinylated goat anti-rabbit secondary antibody
(1:200 dilution; Vector Laboratories, Burlingame, CA, USA) made
up in 0.1% BSA, 0.3% Triton X-100 and 1% normal goat serum in
PBS. Sections were washed and incubated with avidin-conjugatedrs in cultured rat hippocampal neurons. Co-activation of GABAA and
red rat hippocampal neurons. (A) KA-induced whole-cell currents were
A receptors and KA receptors-mediated whole-cell currents. (C, D, E)
ivator Bac with KA induced whole-cell currents. (F) Eﬀects of single
ediated whole-cell currents. The broken line indicated co-application of
rents. (G) Statistic results of GABA receptors inhibiting eﬀects on KA
S.D. (n = 6). aP < 0.05, compared with the expected group, bP < 0.05
e group of KA. KA: 100 lM; GYKI 52466: 30 lM; Mus: muscimol
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37 C, followed by avidin-biotin-peroxidase (ABC, Vector Laborato-
rie) at room temperature. The sections were examined with a light
microscopy.
2.5. Histology
In 4-VO ischemic model, rats were anesthetized with chloral hydrate
and underwent transcardial perfusion with 0.9% saline followed by 4%
paraformaldehyde in 0.1 M PBS. Brains were removed, post-ﬁxed
overnight in paraformaldehyde, processed and embedded in paraﬃn.
Coronal brain sections (6-lm thick) were cut on a microtome. Sections
were de-paraﬃnized in xylene and rehydrated in a gradient of ethanol
and distilled water. The sections were stained with Cresyl violet and
examined with a light microscope and the neuronal density of the hip-
pocampal CA1 pyramidal cells was expressed as the number of cells
per 1-mm length counted under a light microscope (400·).
In MCAO ischemic model, the rats were decapitated 24 h after
reperfusion, and their brains were removed and washed with cold sal-
ine. The site of the suture tip and reperfusion of the MCA were visually
conﬁrmed by the slight dilatation of the vessel without intraluminal
thrombosis. The brains were sliced into 2-mm thick coronal sections.
The slices were immersed in saline containing 2% 2,3,5-triphenyltet-
razolium chloride (TTC) at 37 C in the dark for 30 min. Then the
stained slices were ﬁxed in 10% formaldehyde. Serial coronal sections
were photographed and analyzed by a computer imaging analysis sys-
tem. The total infarct volume for each brain was calculated by summa-
tion of unstained areas of the subsequent slices and multiplying by the
thickness. The volume of the damaged hemisphere was calculated
respectively. The amount of injury was expressed as a ratio of the total
infarct volume to the total volume of the damaged hemisphere.
Other materials and methods used are described in the supplemen-
tary data.3. Results
3.1. Neuroprotective eﬀect of muscimol or/and baclofen on
ischemic cerebral injury in vivo
Cresy1 violet staining was used to examine the surviving cells
of CA1 pyramidal neurons after 5 days reperfusion. Normal
CA1 pyramidal cells showed round and pale stained nuclei.
As shown in Fig. 1A and B, transient cerebral ischemia fol-
lowed by 5 days of reperfusion induced severe cell death
(Fig. 1Ac–d, and B). However, administration of muscimol
or baclofen 30 min before cerebral ischemia signiﬁcantly de-
creased the neuronal degeneration (Fig. 1Ag–j, and B). More-
over, coapplication of muscimol and baclofen signiﬁcantly
increased the survival neurons compared to solely application
of muscimol or baclofen (Fig. 1Ai–k, and B). However, vehicle
control did not show any protection against the degeneration
induced by 5 days of ischemic-reperfusion (Fig. 1Ae–f and B).
Second, we examined the eﬀect of muscimol or/and baclofen
on the infarction size of rats subjected to MCAO. Fig. 1C and
D present the typical results of the eﬀect of MCA occlusion on
infarction size from each of the groups: the MCAO, MCAO-
vehicle treatment, and muscimol and baclofen coapplication
groups. The white-colored areas represent the infarction re-
gions in these sections. As shown in this ﬁgure, coapplication
of muscimol and baclofen signiﬁcantly decreased the amount
of injury. These results indicate that administration of musci-
mol and baclofen have signiﬁcantly neuroprotective eﬀects
against ischemic injury.
3.2. Muscimol and baclofen reduced oxygen-glucose deprivation-
induced apoptosis-like cell death in vitro
Hippocampal neurons were pretreated with muscimol and
baclofen for the indicated concentration 30 min before OGD,and then cells were stained with DAPI. As shown in Fig. 2A
and B, coapplication of muscimol and baclofen signiﬁcantly
enhanced the cell viability against oxygen-glucose deprivation
in hippocampal neurons in a dose-dependent manner, with
maximum level at 15 lmol/L. Administration of muscimol
and baclofen at concentration of 15 lmol/L had no eﬀect on
the cell viability without OGD, but signiﬁcantly decreased
the OGD-induced apoptosis-like cells (Fig. 2C and D).3.3. Cross-inhibition of GABA(A) and GABA(B) receptor with
KA receptors in cultured rat hippocampal neurons
Patch-clamp recording was used to detect the KA receptors-
mediated whole-cell currents (IKA) and the eﬀects of GABAA
and GABAB receptors activators, muscimol (Mus) and baclo-
fen (Bac), on IKA. Muscimol and baclofen induced an intracel-
lular current, and co-application of Mus and Bac with KA
evoked the current with an amplitude that was signiﬁcantly
lower than the expected sum of currents evoked by Mus, Bac
and KA, respectively (68.7% ± 3.3%). The results suggested
that there was a cross-inhibition between IMus+Bac and
IKA(Fig. 3A, B and E). Co-application of Mus with KA also
evoked a lower whole-cell currents than the expected sum of
Mus and KA (84.8% ± 5.7%), whereas Bac did not induce
whole-cell current and had no obvious eﬀect on
IKA(104.7% ± 9.1%, Fig. 3C–E). Moreover, GABA receptor
activators application was followed with KA application to
further investigate relationship between GABA receptor and
KA receptor (Fig. 3F and G). Following co-application of
Mus and Bac or single application of Mus, IKA became much
less than control KA receptor-mediated whole-cell currents
(56.9% ± 4.2% and 69.4% ± 6.4%, respectively).
3.4. Muscimol and/or baclofen suppress the increased assembly
of the GluR6-PSD-95-MLK3 signaling module induced by
ischemic-reperfusion
In our previous study, we found that the interaction of
GluR6 and MLK3 with PSD-95 reached its peak level at 6 h
reperfusion after 15 min ischemia [7]. Immunoprecipitation
and immunoblotting were used to examine the association of
GluR6 and MLK3 with PSD-95 after 15 min ischemia fol-
lowed by 6 h reperfusion in global ischemia model, reciprocal
immunoprecipitation experiments were carried out to conﬁrm
the results. As shown in Fig. 4A–D, the interaction of GluR6
and MLK3 with PSD-95 increased after 15 min ischemia fol-
lowed by 6 h reperfusion. Administration of muscimol and/
or baclofen 30 min prior to ischemia signiﬁcantly diminished
the increased interaction of GluR6, MLK3 with PSD-95.
Meanwhile the protein level of GluR6, PSD-95 and MLK3
were not altered. Note that the eﬀect of coapplication was sig-
niﬁcant when compared to solely application of either musci-
mol or baclofen.3.5. Muscimol and/or baclofen inhibit the activation of MLK3,
MKK4/7 and JNK3 during reperfusion after cerebral
ischemia
Previous studies indicated that MLK3, an upstream kinase
of MKK4/7 and JNK3, could be activated via GluR6 and
PSD-95 [7]. As shown in Fig. 5A and B, 6 h reperfusion after
15 min ischemia resulted in remarkable increase in the
phosphorylation of MLK3. Pretreatment of muscimol and/or
baclofen signiﬁcantly diminished the increase in the
Fig. 4. Eﬀects of pretreatment with muscimol and/or baclofen on the
increased interactions of GluR6 and MLK3 with PSD-95 induced by
6 h of reperfusion following cerebral ischemia (I/R 6 h) in rat
hippocampus. (A, B, C) Co-immunoprecipitation analysis of the
interactions among GluR6, PSD-95 and MLK3. Sample proteins were
immunoprecipitated (IP) with anti-GluR6, anti-PSD-95 or anti-MLK3
antibody and then blotted (IB) with anti-PSD-95, anti-MLK3 or anti-
GluR6 antibody. (D) Quantitative representation of interactions of
GluR6 and PSD-95 with MLK3. Values are represented as
means ± S.D. for four independent experiments (n = 4). aP < 0.05
versus sham; bP < 0.05 versus saline treatment; cP < 0.05 versus
muscimol or baclofen treatment group.
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was not changed. The same dose of control vehicle did not af-
fect the increased phosphorylation of MLK3. Results of wes-
tern blotting revealed that activation of MKK4/7 was
signiﬁcantly suppressed by application of the muscimol and/
or baclofen (Fig. 5C and D). Our previous studies have shown
that JNK3 is signiﬁcantly activated with two peaks at 30 min
and 3 days of reperfusion after transient cerebral ischemia
[7]. The latter peaks are considered to account for delayed neu-
ronal death because prolonged JNK activation above a thresh-
old might be required for brain cell death. We theninvestigated the phosphorylation of JNK3 at 3 days of reper-
fusion. Results revealed that activation of JNK3 was signiﬁ-
cantly suppressed by application of the muscimol and/or
baclofen (Fig. 5E and F).
3.6. Muscimol and/or Baclofen inhibit the activation of c-Jun
and the expression of Fas-L induced by ischemic-reperfusion
Our previous studies indicated that p-c-Jun could be acti-
vated to reach its peak level at 6 h reperfusion after 15 min
ischemia [10]. Western blotting was used to examine the phos-
phorylation of c-Jun. As shown in Fig. 6A and B, muscimol
and/or baclofen can signiﬁcantly prevented the increased c-
Jun activation induced by ischemia, without signiﬁcant eﬀects
on the expression of c-Jun, which was conﬁrmed by the result
of immunohistochemistry (Fig. 6C).
Further more, the expression of Fas-L and Fas were ana-
lyzed by western blotting. As indicated in Fig. 6D and E, the
expression of Fas-L was signiﬁcantly increased 6 h after reper-
fusion. However, application of muscimol and/or baclofen
could diminish the increased expression of Fas-L induced by
cerebral ischemic-reperfusion.The same dose of control vehicle
did not aﬀect the increase on the expression of Fas-L. The pro-
tein level of Fas was not aﬀected. As shown in Fig. 6F, the re-
sults of immunohistochemistry also revealed that weak Fas-L
immunoreactivity was detected in the cytosol of hippocampal
CA1 in the sham group (Fig. 6Fa–b). On the contrary, Fas-L
immunoreactivity was signiﬁcantly increased after 6 h reper-
fusion (Fig. 6Fc–d) compared with the sham group. No
inhibitory eﬀects of control vehicle on Fas-L immunoreactivity
were detected (Fig. 6Fe–f). However, Fas-L immunoreactivity
after 6 h reperfusion was signiﬁcantly inhibited by application
of muscimol and/or baclofen (Fig. 6Fg–l).
Further results are included in the supplementary data.4. Discussion
The goal of the present study was to evaluate whether stim-
ulation of GABA receptors has neuroprotective eﬀects and the
potential mechanisms underlying these eﬀects. Because now
there are conﬂicting evidence about those activating GABA
receptors is directly neuroprotective. Activation of GABA
receptors has been said to be protective [11–13] or not [14].
However, our data presented in this study demonstrate that
pretreatment either with muscimol (GABA(A) receptor ago-
nist) or baclofen (GABA(B) receptor agonist) has neuropro-
tective eﬀects either in vivo or in vitro, and the coapplication
is more eﬀective than single use. Muscimol and baclofen are
two currently used agonists. Both agonists have been tested
in experiment ischemia models, and show neuroprotective ef-
fects, respectively [15,16]. In the present work, cerebral ische-
mic model including global cerebral ischemia and focal
cerebral ischemia (MCAO) in vivo, and OGD model of pri-
mary cultured hippocampal neurons in vitro were adopted to
further test the neuroprotective eﬀects of inhibitory GABA sig-
nal. We report for the ﬁrst time that GABA receptors stimula-
tion can diminish the increased association of PSD-95 with
GluR6 and MLK3 induced by global ischemia, inhibit the acti-
vation of MLK3/JNK3/c-Jun pathway, the Bcl-2 phosphoryla-
tion, the expression of Fas-L, the releases of Bax from Bcl-2/
Bax dimmers and cytochrome c from mitochondria, and the
activation of Caspase 3 during reperfusion after cerebral ische-
Fig. 5. Eﬀects of muscimol and/or baclofen on the activation of MLK3, MKK4/7 and JNK3 in the hippocampal CA1 region after cerebral ischemia.
(A, C, E) Extracts from the CA1 region were subjected to immunoblotting analysis with anti-p-MLK3, anti-MLK3, anti-p-MKK4/7, anti-MKK4/7,
anti-p-JNK3 and anti-JNK3 antibodies, respectively. (B, D, F) Data are expressed as means ± S.D. derived from four independent animals (n = 4).
aP < 0.05 versus sham group; bP < 0.05 versus saline treatment group; cP < 0.05 versus muscimol or baclofen treatment group.
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were signiﬁcant when applied both in vivo and in vitro. More-
over, electrophysiological recording showed that kainate
receptor (KAR)-mediated whole-cell currents could be inhib-
ited by co-activation of GABA receptors in cultured rat hippo-
campal neurons. Taken together, these results suggest that
activation of GABA receptors have neuroprotective eﬀects
when both agonists were applied solely or together.
The normal functions of brain depend on the dynamic bal-
ance of excitation and inhibition. However, cerebral ischemia
can both induce the increase of excitation and the decrease
of inhibition, which leads to neuronal exitotoxicity. Recently,
we found that JNK activation induced by the GluR6-PSD-
95-MLK3 module via KAR play a causal role in cerebral
ischemia [7,8]. In the present study, we ﬁrstly ﬁnd that elevat-
ing the inhibition of GABA receptors can signiﬁcantly de-
crease KAR-mediated excitation after ischemic-reperfusion.
The major ﬁnding is that Muscimol and/or Baclofen can sup-
press the assembly of the GluR6-PSD-95-MLK3 signaling
module during reperfusion after cerebral ischemia. One possi-
ble explanation is that the activation of GABA(A) receptor by
muscimol can induce the hyperpolarization of postsynaptic
nrurons via activating ligand-gated Cl-channels, which de-
crease the depolarization of the neurons [17], and activation
of G-protein-coupled GABA(B) receptor by baclofen can
attenuate glutamate release from presynaptic neurons [18].
The inhibition of excitation after GABA receptors activationmay thereby attenuate the increased association of PSD-95
with GluR6 and MLK3 induced by ischemic excitotoxicity.
Previous studies have provided a detailed characterization of
presynaptic and postsynaptic inhibitory actions of GABA(B)
receptors in the hippocampus [19,20]. Presynaptically located
GABA(B) receptors modulate neurotransmitter release by
depressing Ca2+ inﬂux [21], while postsynaptic GABA(B)
receptors is primarily mediated by G-protein-coupled inwardly
rectifying K+ channels[22]. The widely distributed GABA(B)
protein throughout the hippocampal formation suggest a
underlying cross-talk and mutual regulation between GA-
BA(A) and GABA(B) receptors. Indeed, numerous reports
illustrate that GABA(A) and GABA(B) receptors can mutu-
ally inﬂuence each others ligand binding properties [23,24]
and signaling activity [23,25–27]. Recently, Balasubramanian
et al. [28] found that GABA(B) receptors and GABA(A) recep-
tor subunits are physically associated in native brain tissue.
GABA(B)R1 surface expression can increase the potency of
GABA(A) receptors, and GABA(A) receptor c2S subunit pro-
motes GABA(B)R1 cell surface expression in the absence of
GABABR2. These data suggest that agonist activation of
GABA receptors can be mutually modulated by the associa-
tion between these two diﬀerent classes of GABA receptor.
Additionally, Kulinskii and Mikhelson [29] have found that
GABA(B) receptors agonist baclofen and GABA(A) receptors
agonists THIP and muscimol are additively contribute to the
improvement of brain resistance to global ischemia. As to
Fig. 6. Eﬀects of muscimol and/or baclofen on the increased c-Jun phosphorylation and protein level of Fas-L in the hippocampal CA1 region after
cerebral ischemia. (A, D) Phosphorylation of c-Jun and the protein levels of c-Jun, Fas-L and Fas were examined by immunoblotting analysis with
the indicated antibody. (B, E) Bands on Western blots were scanned and the intensities were expressed as folds versus sham treatment. Values are
represented as means ± S.D. for four independent experiments (n = 4). aP < 0.05 versus sham group; bP < 0.05 versus saline treatment group;
cP < 0.05 versus muscimol or baclofen treatment group. (C, F) Immunohistochemistry analysis of the phosphorylation of c-Jun and the expression of
Fas-L in coronal sections of hippocampi at 6 h of reperfusion. Representative results on ﬁve independent experiments (n = 5) were shown from
immunohistochemical staining sections of the hippocampi from sham operated rats (a, e), rats subjected to 15 min of ischemia followed by 6 h of
reperfusion (c, d), and rats with administration of vehicle (e, f), muscimol (g, h), baclofen (i, j), muscimol and baclofen (k, l) 30 min before ischemia.
Boxed areas in left column are shown at higher magniﬁcation in right column. Scale bar: k = 400 lm, l = 10 lm.
D. Han et al. / FEBS Letters 582 (2008) 1298–1306 1305our ﬁndings in present study that coapplication of GABA(B)
receptors and GABA(A) receptors agonists are more eﬀective
than solely used, our observations further suggest that thesetwo receptor types may cooperate to produce inhibitory synap-
tic transmission.
Further discussion is included in the supplementary data.
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